Edwards Lifesciences (EW) Curent Deferred Tax Liability (2011 - 2014)

Edwards Lifesciences has reported Curent Deferred Tax Liability for 4 years, with the latest figure at $8.3 million in Q4 2014.

• On a quarterly basis, Curent Deferred Tax Liability rose 15.28% year-over-year to $8.3 million in Q4 2014; TTM through Dec 2014 was $8.3 million, a 15.28% increase from a year earlier, with the FY2014 full-year figure at $8.3 million, up 15.28% from the prior year.
• Curent Deferred Tax Liability was $8.3 million for Q4 2014 at Edwards Lifesciences, up from $7.1 million in the prior quarter.
• The five-year high for Curent Deferred Tax Liability was $8.7 million in Q4 2012, with the low at $7.1 million in Q3 2014.
• Average Curent Deferred Tax Liability over 4 years is $8.0 million, with a median of $8.3 million recorded in 2014.
• The sharpest annual moves came in 2013 and 2014: Curent Deferred Tax Liability declined 17.24% in 2013, then climbed 15.28% in 2014.
• Over 4 years, Curent Deferred Tax Liability stood at $8.6 million in 2011, then rose by 1.16% to $8.7 million in 2012, then slipped by 17.24% to $7.2 million in 2013, then rose by 15.28% to $8.3 million in 2014.
• The last three Curent Deferred Tax Liability figures came in at $8.3 million (Q4 2014), $7.1 million (Q3 2014), and $7.2 million (Q4 2013), per Business Quant data.